S-Bank Fund Management Ltd

Bank

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 2036461 HELSINKI, H9

Position in VRTX

as of Jun 30, 2026 · filed Aug 4, 2026 Compact

Position Value

$1,010,348

+$395,463 QoQ

Shares Held

2,034

+47.7% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.14%

of 13F equity value

Holder Rank

#846

of 1,735 holders

Holding Since

Mar 2025

6 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

S-Bank Fund Management Ltd holds $2,967,528 across 5 Biotechnology names. VRTX ranks #1 (34.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma This page	2,034	$1,010,348
2	REGN	Regeneron Pharmaceuticals, Inc.	1,012	$631,022
3	ALNY	Alnylam Pharmaceuticals, Inc.	1,844	$555,099
4	RPRX	Royalty Pharma plc	7,365	$412,955
5	INCY	Incyte Corp	3,159	$358,104

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,010,348	2,034	+47.7%	Shares	Sole	2026-08-04
2026-03-31	$614,885	1,377	-3.6%	Shares	Sole	2026-05-11
2025-12-31	$647,398	1,428	-35.2%	Shares	Sole	2026-02-03
2025-09-30	$863,174	2,204	-1.3%	Shares	Sole	2025-10-27
2025-06-30	$994,131	2,233	-6.6%	Shares	Sole	2025-07-29
2025-03-31	$1,158,719	2,390	—	Shares	Sole	2025-05-13
No filing history on record for this holder in this stock.